Statistics about Health, Pharma & Medtech in United States
Statistics
- Orgenesis gross profit 2016-2023
- Aura Biosciences total equity 2019-2023
- Opgen operating profit 2019-2023
- Organovo Holdings operating profit 2019-2023
- United Therapeutics net income 2015-2019
- Renovorx total equity 2019-2023
- Avalon Globocare Corp. gross profit 2018-2022
- Omeros operating profit 2019-2023
- Avalon Globocare Corp. operating profit 2019-2023
- Avalon Globocare Corp. total assets 2019-2023
- Avalon Globocare Corp. net cash 2019-2023
- Avalon Globocare Corp. total equity 2019-2023
- Avalon Globocare Corp. liabilities 2019-2023
- Avalon Globocare Corp. revenue 2019-2023
- Rhythm Pharmaceuticals total equity 2019-2023
- Avalon Globocare Corp. net income 2019-2023
- Aura Biosciences total assets 2020-2023
- Travere Therapeutics, Inc. total equity 2019-2023
- Aura Biosciences net cash 2020-2023
- Aura Biosciences liabilities 2020-2023
- Oragenics Inc operating profit 2019-2023
- Upexi, Inc. net income 2021-2023
- Reviva Pharmaceuticals Holdings, Inc. total equity 2019-2023
- Recursion Pharmaceuticals total equity 2019-2023
- Aura Biosciences net income 2020-2023
- Aura Biosciences operating profit 2020-2023
- Upexi, Inc. revenue 2020-2023
- United Therapeutics revenue 2019-2023
- Astria Therapeutics, Inc. total assets 2019-2023
- Astria Therapeutics, Inc. total equity 2019-2023
- Rhythm Pharmaceuticals total assets 2019-2023
- Opko Health gross profit 2009-2012
- Oncosec Medical operating profit 2018-2022
- Tyra Biosciences total equity 2019-2023
- Upexi, Inc. gross profit 2020-2023
- Atea Pharmaceuticals total assets 2019-2023
- Dynavax Technologies liabilities 2019-2023
- Davita liabilities 2019-2023
- Davita operating profit 2019-2023
- Davita net cash 2019-2023
- Travere Therapeutics, Inc. liabilities 2019-2023
- Twist Bioscience liabilities 2019-2023
- Davita total equity 2019-2023
- Tyra Biosciences net cash 2020-2023
- Oragenics Inc liabilities 2010-2023
- Davita net income 2019-2023
- Davita total assets 2019-2023
- Otonomy operating profit 2017-2021
- Davita revenue 2019-2023
- Travere Therapeutics, Inc. net cash 2019-2023
- Atea Pharmaceuticals net cash 2019-2023
- Trevi Therapeutics total equity 2019-2023
- Atea Pharmaceuticals total equity 2019-2023
- Oramed Pharmaceuticals operating profit 2019-2023
- Atea Pharmaceuticals liabilities 2019-2023
- Trevi Therapeutics net cash 2019-2023
- Atea Pharmaceuticals revenue 2020-2021
- Twist Bioscience net cash 2019-2023
- Travere Therapeutics, Inc. total assets 2019-2023
- Atea Pharmaceuticals operating profit 2019-2023
- Trevi Therapeutics total assets 2019-2023
- Opko Health operating profit 2019-2023
- Atea Pharmaceuticals net income 2019-2023
- Twist Bioscience total assets 2019-2023
- Tyra Biosciences total assets 2020-2023
- Twist Bioscience total equity 2019-2023
- Recursion Pharmaceuticals total assets 2020-2023
- Astria Therapeutics, Inc. net cash 2019-2023
- Dynavax Technologies revenue 2019-2023
- Oragenics Inc revenue 2013-2023
- Opgen revenue 2019-2023
- Recursion Pharmaceuticals liabilities 2020-2023
- United Therapeutics total assets 2019-2023
- Omeros revenue 2016-2020
- Reviva Pharmaceuticals Holdings, Inc. liabilities 2019-2023
- Upexi, Inc. total equity 2019-2023
- Rhythm Pharmaceuticals operating profit 2019-2023
- Denali Therapeutics net cash 2019-2023
- Denali Therapeutics total equity 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. operating profit 2019-2023
- Denali Therapeutics liabilities 2019-2023
- Recursion Pharmaceuticals operating profit 2019-2023
- Denali Therapeutics total assets 2019-2023
- Denali Therapeutics operating profit 2019-2023
- Denali Therapeutics revenue 2019-2023
- Rhythm Pharmaceuticals liabilities 2019-2023
- United Therapeutics total equity 2019-2023
- Otonomy net income 2017-2021
- Ultragenyx Pharmaceutical net income 2016-2020
- Ultragenyx Pharmaceutical revenue 2019-2023
- Ultragenyx Pharmaceutical operating profit 2019-2023
- Oramed Pharmaceuticals net income 2019-2023
- Rhythm Pharmaceuticals revenue 2019-2023
- Opko Health net income 2014-2018
- Opgen net income 2017-2021
- Ayala Pharmaceuticals total equity 2019-2023
- Recursion Pharmaceuticals revenue 2019-2023
- Dice Therapeutics, Inc. total equity 2019-2022
- Ayala Pharmaceuticals operating profit 2019-2023
- Ayala Pharmaceuticals revenue 2019-2023